CVS

Three companies, including CVS, have filed lawsuits challenging Tennessee Gov. Bill Lee's 'Fair Rx Act,' which restricts companies from owning pharmacies, pharmacy benefit managers, and insurers starting July 1, 2028. Supporters argue the law limits corporate control in the prescription drug system, while CVS claims it will close 134 pharmacies, increase drug costs, and violate the Dormant Commerce Clause by targeting out-of-state businesses.

Tennessee lawmakers passed a bill banning pharmacy benefit managers (PBMs) from owning pharmacies, leading to lawsuits from CVS, Express Scripts, and the Pharmaceutical Care Management Association. The law, called the Fair Rx Act, was supported by lawmakers with ties to local pharmacies and the Tennessee Pharmacists Association. Similar legislation in Arkansas faced legal challenges and was blocked by a federal judge.

Insurance companies are increasingly dropping coverage for weight loss drugs like Wegovy and Zepbound due to rising costs, pushing patients to purchase through telehealth providers or manufacturers. Hims partners with Wegovy to offer the drug directly, while CVS expands coverage for Eli Lilly's anti-obesity pill and reinstates Zepbound later this year.

A man was injured during a shootout in Miami Gardens after he attacked his ex-girlfriend and fired at two men who defended her. The attacker fled to a CVS and was hospitalized with non-life-threatening injuries after a confrontation involving the victim's brother and an intervening man.

Police are investigating a break-in at a CVS store near Vernor Highway and Campbell Street in Detroit. Thieves used a front-end loader to break down the wall overnight Saturday.

CVS executives banned a cat named Nutmeg from retiring in a Portland store due to hygiene concerns. The decision sparked public backlash.

CVS will cover Lilly’s GLP-1 medications, Foundayo (a pill) and Zepbound (an injection), potentially expanding access for millions of Americans.

H1 has secured $40 million in funding from CVS. CEO Ariel Katz claims that while AI can replicate workflow SaaS, it cannot copy H1’s unique doctor data.

Mount Sinai has filed a lawsuit against CVS, alleging a $121 million racketeering scheme where the pharmacy chain illegally diverted federal prescription drug discounts intended for low-income New York patients. The hospital system claims CVS operated a secret pricing scheme to pocket savings from the federal 340B drug discount program.

CVS reported better-than-expected results, extending its winning streak in the healthcare sector. The company's performance was driven by strong growth in its pharmacy services and health insurance businesses. This positive trend is expected to continue, with CVS well-positioned for future success.

CVS exceeded estimates and raised its outlook due to strong performance across all business segments, including Aetna insurance and retail pharmacy services. The health-care giant's insurer Aetna and its retail pharmacy and health services unit surpassed expectations. This positive outcome reflects the company's overall growth.

CVS has increased its outlook for 2026 after seeing a boost in profits from Aetna. The company's improved financial performance is attributed to the growth of its health insurance business. This increase in profits positions CVS for potential future expansion and investment.

The article discusses the thirty-year history of source control, from CVS to Git. It highlights the evolution of version control systems and their impact on software development. The article is available on the Evil Genius Labs blog.

CVS disputes Planned Parenthood's claim of a 'strategic partnership' regarding abortion pill access, as the organization removed such language from its annual report. CVS maintains it only dispenses prescriptions legally, while critics argue the arrangement could make CVS the first publicly traded company to distribute abortion pills. Planned Parenthood did not directly address the term 'strategic partnership' but affirmed expanded access to abortion care through pharmacy pickups.

CVS disputes Planned Parenthood's claim of a 'strategic partnership' for abortion pill access, stating their role is limited to prescription dispensing. Planned Parenthood's annual report previously referenced the partnership but removed the language by April 2026, sparking criticism from anti-abortion advocates.